USPSTF reaffirms advice against COPD screening in adults with no symptoms
NEW YORK 11/05 - The U.S. Preventive Services Task Force (USPSTF) has reaffirmed its recommendation against screening for chronic obstructive pulmonary disease (COPD) in individuals who do not have relevant symptoms.
In 2020 it was estimated that roughly 6% of U.S. adults had been diagnosed with COPD.
To update its 2016 recommendation, the USPSTF commissioned an updated evidence review on the potential benefits and harms of screening for COPD in asymptomatic adults.
The review found that screening for COPD in asymptomatic adults has "no net benefit," the group reports in JAMA.
Given that the review found "no new substantial evidence that could change its recommendation" they reaffirmed its earlier "D" recommendation against screening for COPD in asymptomatic adults.
The authors of an editorial caution that the USPSTF recommendation "should not be taken as a signal to stop research on screening for COPD," given the substantial morbidity and mortality associated with COPD.
"Even though available data may not support screening asymptomatic adults for COPD, there is substantial rationale for further investigation of strategies to enhance earlier detection of this condition," write Dr. George O'Connor of Boston University School of Medicine and Dr. Surya Bhatt of the University of Alabama at Birmingham.
Vous désirez lire la suite de cet article ?
Inscrivez-vous gratuitement pour accéder à tous les contenus de Mediquality sur tous vos écrans.